NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



New findings in the area of breast cancer described



July 28th, 2005

Investigators in the United States have published new breast cancer data.

Study 1: HER-2 overexpression inversely correlates with estrogen and progesterone receptor expression in invasive breast cancer.

"We studied the inverse relationship between HER-2 and estrogen (ER) and progesterone (PR) receptors using HER-2 testing and correlated HER-2 status with histologic features in 3,655 unselected invasive breast carcinomas.

"Immunohistochemical analysis for ER, PR, HER-2, and fluorescence in situ hybridization for HER-2 was performed," researchers in the United States report.

"ER and PR expression were decreased...


Source: Women's Health Weekly (2005-07-28)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login